We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current INMB market cap is 115.52M. The company's latest EPS is USD -1.3534 and P/E is -3.91.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 43k | 28k | 14k | 0 | 0 |
| Operating Income | -8.53M | -8.38M | -11.02M | -9.87M | -12.29M |
| Net Income | -8.56M | -8.41M | -11.03M | -9.75M | -12.09M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.54M | 11k | 181k | 374k | 155k |
| Operating Income | -7.76M | -12.23M | -29.15M | -25.95M | -29.74M |
| Net Income | -7.68M | -12.1M | -30.34M | -27.3M | -30.01M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 62.7M | 57M | 46.83M | 52.45M | 52.78M |
| Total Liabilities | 17.97M | 18.86M | 17.81M | 15.37M | 14.11M |
| Total Equity | 43.93M | 37.34M | 28.22M | 36.28M | 38.68M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 24.47M | 40.66M | 99.95M | 81.8M | 57M |
| Total Liabilities | 860k | 1.9M | 19.72M | 21.69M | 18.86M |
| Total Equity | 23.61M | 38.75M | 80.23M | 60.1M | 37.34M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -8.58M | -11.98M | -7.48M | -15.36M | -22.35M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | -1.73M | -4.23M | -2.5M | 10.5M | 20.29M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -5.38M | -8.94M | -28.5M | -22.69M | -11.98M |
| Investing | N/A | N/A | -15M | N/A | N/A |
| Financing | 12.21M | 23.9M | 96.36M | 729k | -4.23M |
| Market Cap | 115.52M |
| Price to Earnings Ratio | -3.91 |
| Price to Sales Ratio | 755.71 |
| Price to Cash Ratio | 3.27 |
| Price to Book Ratio | 3.08 |
| Dividend Yield | - |
| Shares Outstanding | 22.17M |
| Average Volume (1 week) | 241.99k |
| Average Volume (1 Month) | 226.76k |
| 52 Week Change | -53.02% |
| 52 Week High | 14.74 |
| 52 Week Low | 4.32 |
| Spread (Intraday) | 2.95 (39.6%) |
| Company Name | INmune Bio Inc |
| Address |
701 s carson st carson city, nevada 89701 |
| Website | https:// |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
